Estia Health Ltd (ASX: EHE) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Estia Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $575.17 million
P/E Ratio 178.57
Dividend Yield 2.20%
Shares Outstanding 261.44 million
Earnings per share 0.012
Dividend per share 0.05
Year To Date Return -7.24%
Earnings Yield 0.56%
Franking 100%
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Estia Health Ltd (ASX: EHE)
Latest News

busy trader on the phone in front of board depicting asx share price risers and fallers
Broker Notes

2 ASX shares to buy now, no matter what else happens this year: experts

Turbulent times in the world mean not all cheap shares actually have good prospects. Here are a pair of suggestions…

Read more »

A surprised and curious male investor drinks black coffee while reading the latest news on rising ASX shares in the newspaper
Broker Notes

Here are the latest broker updates from Macquarie. It’s not all pretty for ASX shares.

Macquarie is the latest broker to release its buy and sell tips in early 2022.

Read more »

healthcare worker overseeing group of aged care residents at table
Healthcare Shares

Why this fundie says Estia Health (ASX:EHE) shares are a smart pick for 2022

Here's why this fundie is bullish on the aged care provider's stock.

Read more »

Bluescope share price Man jumping from 2021 cliff to 2022 cliff
Best Shares

Fundies reveal their 2 top ASX shares for 2022

Fundies pick these two companies as their number one picks for 2022...

Read more »

stock market gaining
Share Gainers

Why Chalice, De Grey, Estia Health, and Fortescue shares are racing higher

These ASX shares are rising on Thursday...

Read more »

healthcare worker overseeing group of aged care residents at table
Earnings Results

Estia Health (ASX:EHE) share price falls on FY21 earnings

It wasn't an easy financial year for the residential aged care provider.

Read more »

an elderly woman wearing boxing gloves raises one toward her face in a boxing pose while looking towards the camera with grey hair and spectacles on.
Share Gainers

This beaten-up sector has some of the top performing ASX shares this year

ASX aged care shares have emerged as top performers this year after slumping as much as 80% between 2016 and…

Read more »

asx buy
Broker Notes

Brokers name 3 ASX shares to buy now

Brokers have named REA Group Limited (ASX:REA) and these ASX shares as buys this week. Here's why they are bullish…

Read more »

Frequently Asked Questions

Estia Health typically pays twice yearly, fully franked dividends in late March and either late September or early October each year. Most recently, Estia paid its interim dividend of 5.4 cents per share on 23 March 2020.

Yes. Estia Health offers shareholders residing in Australia and New Zealand the option of either full or partial participation in its dividend reinvestment plan. Shareholders residing in other jurisdictions may also be eligible to participate under certain circumstances. The Estia Board may, at any time, determine that the DRP will not apply to a particular dividend payment by making an announcement to the market.

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
25 Feb 2022 $0.0235 100.00% Interim 18 Mar 2022
27 Aug 2021 $0.0230 100.00% Final 17 Sep 2021
28 Feb 2020 $0.0540 100.00% Interim 27 Mar 2020
04 Sep 2019 $0.0780 100.00% Final 02 Oct 2019
05 Mar 2019 $0.0800 100.00% Interim 27 Mar 2019
06 Sep 2018 $0.0800 100.00% Final 28 Sep 2018
01 Mar 2018 $0.0780 100.00% Interim 23 Mar 2018
07 Sep 2017 $0.0800 100.00% Final 29 Sep 2017
30 Sep 2016 $0.1280 100.00% Final 07 Nov 2016
22 Mar 2016 $0.1280 100.00% Interim 20 Apr 2016
28 Sep 2015 $0.1360 100.00% 26 Oct 2015

EHE ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Estia Health Ltd

Estia Health Ltd (EHE) is one of Australia’s largest residential aged care providers. The company delivers care to more than 8,000 older Australians each year from its homes which are located along the eastern seaboard of Australia and South Australia.

Estia Health was established in 2014 through the merger of 3 residential aged care businesses. Despite the Estia Health share price quickly rising after listing on the ASX that very year, Estia Health shares did not enjoy such success in the latter half of the decade. Nonetheless, as an aged care provider, the company is supported by ageing population tailwinds.

EHE Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 May 2022 $2.20 $0.09 4.27% 675,675 $2.10 $2.23 $2.10
13 May 2022 $2.11 $0.01 0.48% 602,279 $2.12 $2.16 $2.09
12 May 2022 $2.10 $-0.05 -2.33% 323,528 $2.15 $2.16 $2.08
11 May 2022 $2.15 $0.01 0.47% 317,951 $2.25 $2.25 $2.13
10 May 2022 $2.14 $-0.03 -1.38% 404,590 $2.16 $2.16 $2.07
09 May 2022 $2.17 $-0.10 -4.41% 472,156 $2.22 $2.25 $2.14
06 May 2022 $2.27 $-0.02 -0.87% 326,757 $2.29 $2.29 $2.19
05 May 2022 $2.29 $0.06 2.69% 149,857 $2.26 $2.29 $2.21
04 May 2022 $2.23 $-0.06 -2.62% 287,323 $2.28 $2.30 $2.23
03 May 2022 $2.29 $-0.02 -0.87% 267,351 $2.30 $2.30 $2.23
02 May 2022 $2.31 $-0.02 -0.86% 217,782 $2.33 $2.34 $2.26
29 Apr 2022 $2.33 $0.03 1.30% 131,647 $2.31 $2.33 $2.29
28 Apr 2022 $2.30 $-0.03 -1.29% 216,454 $2.35 $2.35 $2.29
27 Apr 2022 $2.33 $0.06 2.64% 260,895 $2.26 $2.33 $2.21
26 Apr 2022 $2.27 $-0.07 -2.99% 509,497 $2.32 $2.32 $2.25
22 Apr 2022 $2.34 $-0.04 -1.68% 85,970 $2.38 $2.38 $2.32
21 Apr 2022 $2.38 $0.07 3.03% 334,341 $2.33 $2.38 $2.29
20 Apr 2022 $2.31 $-0.08 -3.35% 767,163 $2.39 $2.41 $2.28

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
22 Nov 2021 Ian Thorley Expiry 201 $436,868
As advised by the company. 1,221,738 - performance rights
Lapse of FY19 long term performance rights
22 Nov 2021 Ian Thorley Issued 335 $727,060
Issue of securities. 1,423,060 - performance rights
22 Nov 2021 Norah Barlow Expiry 103 $225,426
As advised by the company.
26 Aug 2021 Karen Penrose Buy 4 $10,642
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Gary Hilton Weiss Non-Executive DirectorNon-Executive Chairman Feb 2016
Dr Weiss has international business experience and has been involved in numerous cross-border mergers and acquisitions. Gary is Chairman of Cromwell Property Group Limited and Ardent Leisure Group Limited, Executive Director of Ariadne Australia Limited, and a Director of Thorney Opportunities Limited and Hearts and Minds Investments Limited. Gary is also a Commissioner of the Australian Rugby League Commission and a Director of the Victor Chang Cardiac Research Institute. Gary was Chairman of Coats Group plc from May 2004 to April 2012, Chairman of Clearview Wealth Ltd from 2013 to May 2016, Chairman of Ridley Corporation from June 2015 to June 2020, Executive Director of Guinness Peat Group plc from 1990 to April 2011 and has held directorships of numerous companies, including The Straits Trading Co Limited, Tag Pacific Limited, Pro-Pac Packaging Limited, Premier Investments Ltd, Westfield Group, Tower Australia Limited, Australian Wealth Management Limited, Tyndall Australia Limited (Deputy Chairman), Joe White Maltings Limited (Chairman), CIC Limited, Whitlam Turnbull & Co Limited and Industrial Equity Limited. Gary has authored numerous articles on a variety of legal and commercial topics. Gary was awarded a Member of the Order of Australia (AM) in recognition of his services to business and to the community. Dr Weiss is member of Property and Investment Committee, COVID-19 Committee, Royal Commission and chair of Regulatory Committee. Other directorships includes Ariadne Australia Limited, Ardent Leisure Group Limited (Chair), Thorney Opportunities Ltd, Hearts and Minds Investments Limited, Cromwell Property Group (Chair), Straits Trading Co. Ltd (resigned 30 September 2020), Ridley Corporation Limited (resigned 26 August Ridley Corporation Limited (resigned 26 August 2020), Premier Investments Limited (28 July 2018).
Mr Ian Thorley Chief Operating OfficerChief Executive OfficerManaging Director Nov 2018
Mr Thorley has over 30 years health and aged care experience in both Australia and overseas. Appointed as Chief Executive Officer in October 2018, Ian was previously Estia Health's Chief Operating Officer from October 2016. Ian's executive experience includes CEO and COO roles in large aged care groups, acute private hospital groups and diagnostic services in Australia and internationally. Ian has been at the forefront of major developments that have shaped Australia's healthcare sector, including the privatisation of public hospitals, new reimbursement and funding models, and a broad range of public/private sector service models. Ian has held the position of Non-executive Director in private equity owned, and ASX listed companies and has consulted to aged care operators, private hospital groups, health insurers and health logistics businesses throughout Australia.
Ms Helen Kurincic Non-Executive Director Jul 2017
Ms Kurincic has executive and Non-executive experience across the healthcare sector. Helen is Chairman of Integral Diagnostics Limited and McMillan Shakespeare Limited, and a Non-executive Director of HBF Health Limited and Victorian Clinical Genetics Service. Helen was previously the Chief Operating Officer and Director of Genesis Care for seven years from early inception in 2007, creating Australia's largest radiation oncology and cardiology service business. Previous roles also include Non-executive Director of Sirtex Medical Limited, Non-executive Director of DCA Group Limited which included residential aged care in Australia and New Zealand, Non-executive Director of AMP Capital Investor's aged care business Domain Principal Group, CEO and Executive Director of residential aged care provider Benetas and Board member of Melbourne Health and Orygen Research Centre. Helen has also been actively involved in government policy reform across various areas of the healthcare sector. She is chair of Risk Management Committee and COVID-19 Committee.
Ms Karen Lee Collett Penrose Non-Executive Director Oct 2018
Ms Penrose is an experienced Company Director who has served as a full-time Non-executive Director since 2014 on the boards of ASX listed companies across the financial services, aged care, healthcare, resources and infrastructure sectors. Karen's executive career was in leadership and CFO roles, mainly in financial services. Karen worked with CBA and HSBC for over 20 years. She is passionate about consumer outcomes and financial management and is well-versed in operating in a rapidly changing regulatory environment. Karen is a Director and Chair of the Audit Committee of Bank of Queensland, Ramsay Health Care and Vicinity Centres. She is also Director of Marshall Investments Pty Ltd and Rugby Australia Limited. Karen was formally a director of Future Generation Global Investment Company Limited, AWE Limited and Spark Infrastructure Group Limited. Karen is a member of Chief Executive Women. She is member of Risk Management Committee, Royal Commission & Regulatory Committee, COVID-19 Committee. Other Directorships includes: Bank of Queensland Limited, Vicinity Centres, Ramsay Health Care, Spark Infrastructure Group (resigned May 2020), Future Generation Investment Company Limited (resigned October 2018).
Ms Norah Kathleen Barlow Non-Executive Director Nov 2014
Ms Barlow is amongst Australasia's most experienced and respected executives and directors, with an in-depth knowledge of the aged and healthcare sector. Norah also holds experience as the highly-respected former CEO and former Director of Summerset Group, an NZX and ASX-listed company named Australasia's best retirement village operator four years running. Norah has a background across business leadership and management, strategy, corporate finance, governance, tax and accounting. Norah was President of the Retirement Villages Association (NZ) for seven years and made an Officer of the New Zealand Order of Merit for services to business in 2014. Norah was also a Non-executive Director of Ingenia Communities Group, Evolve Education Group Limited, and chair of the Audit Committee for Methven Limited. Norah stepped down as CEO of Estia Health in November 2018 and remains on the board as a Non-executive Director. Norah is currently Chief Executive of Heritage Lifecare Limited. She is member of Property and Investment Committee. She is former director of Evolve Education Group Limited.
Mr Paul Foster Non-Executive Director Feb 2016
Mr Foster is an experienced Financial Services professional and Company Director, with more than 20 years of investment experience in the infrastructure, private equity and real estate asset classes, including substantial investments in the healthcare sector. Paul is a Managing Director at Pacific Equity Partners, one of Australia's largest alternative investment management firms. He is also a Non-executive Director of WINconnect Pty Ltd, PEP Services Pty Ltd and PEP Advisory Services Pty Ltd. Paul was a Director of the Opal Aged Care Group (formerly Domain Principal Group) between 2010 and 2015 and was Chairman of the Group in 2011. Paul was head of AMP Capital's Infrastructure investment business in Australia and New Zealand until 2015. Before AMP Capital, he was an investment professional at Macquarie Group and Perpetual Investments. He is member of Risk Management Committee and Property and Investment Committee.
Ms Leanne Ralph Company Secretary Apr 2019
Steve Lemlin Chief Financial Officer
Leanne Ralph Company Secretary
Sean Bilton Deputy Chief Executive Officer and Chief Operating Officer

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
J P Morgan Nominees Australia Pty Limited 44,825,404 17.15%
HSBC Custody Nominees (Australia) Limited 38,159,037 14.60%
Citicorp Nominees Pty Limited 35,835,232 13.71%
National Nominees Limited 17,636,454 6.75%
Network Investment Holdings Pty Ltd 17,245,858 6.60%
Argo Investments Limited 11,809,250 4.52%
Network Investment Holdings Pty Ltd i 10,000,000 3.82%
BNP Paribas Noms Pty Ltd <DRP> 9,447,392 3.61%
3rd Wave investors Pty Ltd 4,250,000 1.63%
Emalyn Holdings Pty Limited <JOHN KENNEDY A/C> 4,102,766 1.57%
Bnp Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 3,663,626 1.40%
HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C> 2,340,873 0.90%
Mr Mark Edward Kennedy <MARK EDWARD KENNEDY A/C> 1,910,678 0.73%
Mrs Julia Michelle Manken & Mr Mike Darren Manken & Miss Jessica Kelly Manken 1,525,000 0.58%
Skip Enterprises Pty Ltd <FARQUHAR A/C> 1,442,768 0.55%
Mark Edward Kennedy <MARK EDWARD KENNEDY FAMILY> 1,277,438 0.49%
Custodial Services Limited <BENEFICIARIES HOLDING A/C> 1,202,809 0.46%
Kennbros Pty Limited 1,156,834 0.44%
CS Third Nominees Pty Limited <HSBC Cust Nom Au Ltd 13 A/C> 1,141,150 0.44%
Alphagen Capital Pty Ltd 1,000,000 0.38%